Coronavirus: CEN and CENELEC introduce new guidelines for meetings  

Due to the growing concerns on the global outbreak of coronavirus (COVID-19), CEN and CENELEC have taken a series of preventive measures and are closely monitoring guidance of the World Health Organization, the European Centre for Disease Prevention and Control and the Belgian authorities.

The new measures taken concern meetings organised in Brussels until 30 April 2020, and regard events organised and supported by the CEN and CENELEC Management Centre (CCMC). With the aim to ensure as much as possible the continuity of business, the majority of meetings will be maintained, but they will be organised virtually only.

The 2020 edition of StandarDays, foreseen for April 2nd and 3rd, is to be postponed to a date still to be determined. CEN and CENELEC will keep all registered participants informed on the new date and apologise for the inconveniences this might cause.

For the meetings foreseen to be taking place in May, information will be provided by the end of March. However, the Stakeholders Engagement Workshop on Artificial Intelligence and eHealth, originally scheduled for May 14th, is postponed to a later date to be communicated.

In the meantime, the CEN-CENELEC Meeting Centre is still open and will apply the instructions from the Belgian federal authorities.

Finally, concerning technical bodies meetings, the decision to maintain, postpone or cancel a scheduled meeting at the CEN-CENELEC Meeting Centre remains with the Member holding the secretariat. To ensure business continuity we encourage holding virtual meetings and making full use of online tools. In any case, the organisers of meetings are encouraged to inform the participants at least 5 days in advance, in order to allow for necessary changes to be taken as smoothly as possible.
 
More information on our web-conference services is available on the CEN-CENELEC website.

CEN and CENELEC will monitor closely the evolution of the situation and update these guidelines in line with any further developments.

For more information, please contact Giovanni COLLOT.